An in vitro study by Xue et al. in triple-negative breast cancer cell lines showed that metformin synergistically with an insulin/IGF-1 receptor inhibitor suppressed skp2, which in turn stabilized p27. Here, INS is linked to triple-negative breast carcinoma.